Thrive Earlier Detection Corp., a cancer diagnostics startup that spun out of Johns Hopkins this year with $110 million in funding, has appointed a health care industry veteran as its new CEO. David J. Daly will take over the helm at Thrive, and become a board member on Aug. 19. He will succeed interim CEO, Steven J. Kafka, a partner at Thrive’s lead investor Third Rock Ventures. Kafka will become executive chairman of the company’s board. Daly has over 25 years of executive leadership experience…
from https://www.bizjournals.com/baltimore/news/2019/08/01/johns-hopkins-cancer-diagnostics-spinoff-appoints.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/186704137607
No comments:
Post a Comment